The results showed that niclosamide increased ROS levels and decreased GSH levels, which was accompanied with an increase in MDA levels; these findings were consistent in all four colon cancer cell lines (HCT-116 cells with and without p53 and SW48 cells with and without the G12D mutation in KRAS) (Figure 13). The gene discussed is KRAS; the disease is malignant colon neoplasm.